Abstract
The urinary bladder is lined by highly specialized epithelium, so-called urothelium or transitional cell epithelium. One specific characteristic of this urothelium is the ability to protect the human body against reabsorption of toxic elements excreted by the kidney. The constantly changing volume of urine in the bladder requires a high degree of stretching of the covering epithelium, while maintaining an intact barrier function. Unfortunately this highly specialized epithelium shows a strong tendency to develop neoplastic disease. In most industrialized parts of the world, bladder cancer constitutes an important issue in oncological health care (RĂ¼bben 1985).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Baak JPA, Oort J (1983) A manual of morphometry in diagnostic pathology. Springer, Berlin Heidelberg New York, pp 18–20
Badalament RA, Hermansen DK, Kimmel M (1987) The sensitivity of bladder wash flowcytometry. Bladder wash cytology and voided cytology in the detection of bladder carcinoma. Cancer 60: 1423–1427
Beahrs OH, Meyers MD (1983) Manual for staging of cancer, 2nd edn. Lippincott, Philadelphia, p 173
Bergkvist A, Ljungqvist G, Moberger G (1965) Classification of bladder tumours based on the cellular pattern. Acta Chir Scand 130: 371–378
Blomjous CE, Smeulders AWM, Vos W, Baak JPA, van Galen EM, Meyer CJLM (1988) Retrospective study of prognostic importance of DNA flowcytometry of urinary bladder transitional cell carcinoma. J Clin Pathol 41: 21–25
Blomjous CE, Schipper NW, Vos W, Baak JPA, de Voort HJ, Meijer CJLM (1989) Comparison of quantitative and classic prognosticators in urinary bladder carcinoma. A multivariate analysis of DNA flowcytometric, nuclear morphometric and clinicopathological features. Virchows Arch [A] 415: 421–428
Boon ME, Blomjous CEM, Zwartendijk J, Heinhuis RJ, Ooms ECM (1986) Carcinoma in situ of the urinary bladder. Clinical presentation, cytologic pattern and stromal changes. Acta Cytol 30: 360
Borland RN, Partin AW, Epstein JI, Brendler CB (1993) The use of nuclear morphometry in predicting recurrence of transitional cell carcinoma. J Urol 149: 272–275
Broders AC (1992) Epithelioma of genito-urinary organs. Ann Surg 75: 574–580
Collan Y, Makinen J, Heikkinen A (1979) Histologic grading of transitional cell tumors of the bladder: value of histologic grading ( WHO ). Eur Urol 5: 311
Louts AG, Grigor KM, Fowler JW (1985) Urothelial dysplasia and bladder cancer in cystectemy specimens. Br J Urol 57: 535
Devere White RW, Deitch AD, West B, Fitzpatrick JM (1988) The predictive value of flowcytometric information in the clinical management of stage 0–Ta bladder cancer. J Urol 139: 279–285
Farrow G (1987) Histopathology and cytopathology of bladder cancer. In: Javadpour N, Barsky SH (eds) Surgical pathology of urologic diseases. Williams and Wilkins, Baltimore, p 154
Friedell GH, Bell JR, Burney SW, Soto EA, Tiltman AJ (1976) Histopathology and classification of urinary bladder carcinoma. Urol Clin North Am 3: 53–70
Gilbert HA, Logan JL, Kagan AR (1976) The natural history of papillary transitional cell carcinoma of the bladder and its treatment in an unselected population on the basis of histologic grading. J Urol 119: 488
Hermanek B, Sobin LH (1987) T.N.M. classification of malignant tumors, Union International Contre le Cancer (UICC), 4th edn. Springer, Berlin Heidelberg New York, pp 121–144
Jewett HJ, Strong GH (1946) Infiltrating carcinoma of bladder: relation of depth of penetration of bladder wall to incidence of local extension and metastasis. J Urol 55: 366–372
Jordan AM, Weingarten J, Murphy WM (1987) Transitional neoplasms of the urinary bladder. Cancer 60: 2766–2770
Klein FA, Herr HW, Sogani PC, Withmore WP, Melamed MR (1982) Detection and follow-up of carcinoma of the urinary bladder by flowcytometry. Cancer 50: 389
Koss LG (1979) Mapping of the urinary bladder: its impact on the concepts of bladder cancer. Hum Pathol 10: 533–548
Koss LG, Dietch D, Ramanathan R, Sherman AB (1985) Diagnostic value of cytology of voided urine. Acta Cytol 29: 810–816
Lipponen PK (1993a) Over-expression of p 53 nuclear oncoprotein in transitional cell bladder cancer and its prognostic value. Int J Cancer 53: 365–370
Lipponen PK (1993b) Expression of c-erb B-2 oncoprotein in transitional cell bladder cancer. Eur J Cancer 29A: 749–753
Lipponen PK, Aaltomaa S (1994) Apoptosis in bladder cancer as related to standard prognostic factors and prognosis. 173: 333–339
Lipponen PK, Eskelinen M (1994) Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erb B-2, p 53) expression and long-term prognosis. Br J Cancer 69: 1120–1125
Lipponen PK, Collan Y, Eskelinen MJ, Pesonen E, Sotarauta M, Nordling S (1990a) Comparison of morphometry and DNA flowcytometry with standard prognostic factors in bladder cancer. Br J Urol 65: 589
Lipponen PK, Eskelinen MJ, Sotarauta M (1990b) Prediction of superficial bladder cancer by histoquantitative methods. Eur J Cancer 26: 1060–1063
Lipponen PK, Kosma VM, Collan Y, Kulju T, Kosunen E, Eskeli nen M (1990c) Potential of nuclear morphometry and volume-corrected mitotic index in grading transitional cell carcinoma of the urinary bladder. Eur Urol 17: 333
Malmström PU, Norlen BJ, Andersson B, Busch C (1989) Combination of bloodgroup ABH antigen status and DNA ploidy as independent prognostic factor in transitional cell carcinomas. Scand J Urol Nephrol 64: 49–55
Marshall VF (1962) The relation of the preoperative estimate to the pathologic demonstration of the extent of vesicle neoplasms. J Urol 68: 714–723
Mostofi FK, Sobin LH, Torloni H (1973) In: Histological typing of urinary bladder tumours. International histological classification of tumours, no 10. World Health Organisation (WHO), Geneva
Murphy WM, Soloway MS (1982) Urothelial dysplasia. J Urol 127: 849
Murphy WM, Beckwith JB, Farrow GM (1993a) Atlas of tumor pathology, tumors of the kidney, bladder and related urinary structures. Armed Forces Institute of Pathology, Washington, pp 210–219
Murphy WM, Beckwith JB, Farrow GM (1993b) In: Atlas of tumor pathology, tumors of the kidney, bladder and related urinary structures. Armed Forces Institute of Pathology, Washington, pp 228–230
Murphy WM, et al. (1993c) pp 193–275
Nielsen K, Colstrup H, Nilsson T, Gundersen HJG (1986) Stereological estimates of nuclear volume correlated with histopathological grading and prognosis of bladder tumours. Virchows Arch [A] 52: 41
Ooms ECM, Veldhuizen RW (1993) Cytological criteria and diagnostic terminology in urinary cytology. Cytopathology 4: 51–54
Ooms ECM, Essed E, Veldhuizen RW, Alons CL, Kurver PHJ, Boon ME (1981) The prognostic significance of morphometry in T1 bladder tumours. Histopathology 5: 311–318
Ooms ECM, Kurver PHJ, Veldhuizen RW, Alons CL, Boon ME (1983) Morphometric grading of bladder tumours in comparison with histologic grading by pathologists. Hum Pathol 14: 144–150
Ooms ECM, Blok APR, Veldhuizen RW (1985) The reproducibility of a quantitative grading system of bladder tumours. Histopathology 9: 501–509
Reuter VE (1990) Pathology of bladder cancer. Assessment of prognostic variables and response to therapy. Semin Oncol 17: 524–532
RĂ¼bben H, Lutzeyer W, Wallace DMA (1985) The epidemiology and aetiology of bladder cancer. In: Zingg EJ, Wallace DMA (eds) Bladder Cancer. Springer, Berlin Heidelberg New York, p 1
Russell PJ, Brown JL, Grimmond SM, Ragvahan D (1990) Review molecular biology of urological tumours. Br J Urol 65: 121–130
Sarkis AS, Dalbagni G, Cordon-Cardo C, et al. (1993) Nuclear over expression of p 53 protein in transitional cell bladder carcinoma: a marker for disease progression. J Natl Cancer Inst 85: 53–59
Schapers RFM, Pauwels RPE, Havenith ME, Smeets AWGB, van den Brandt PA, Bosman FT (1990) Prognostic significance of type IV collagen and laminin immunoreactivity in urothelial carcinomas of the bladder. Cancer 66: 2583–2588
Shimazui T, Koiso K, Uchiyama Y (1990) Morphometry of nucleoli as an indicator for grade of malignancy of bladder tumors. Virchows Arch [B] 59: 179
Soiny Y, Turpeenniemi-Hujanen T, Kamel D (1993) p 53 Immuno histochemistry in transitional cell carcinoma and dysplasia of the urinary bladder correlates with disease progession. Br J Cancer 68: 1029–1035
van der Poel HG, van Cambergh RD, Boon ME, Debruyne FMJ, Schalken JA (1992) Karyometry in recurrent superficial transitional cell tumours in the bladder. Urol Res 20: 375–381
Vasco J, Malinström PU, Taube A, Wester K, Busch C (1991) Prognostic value of a systematized method for determination of mitotic frequency in bladder cancer assisted by computerized image analysis. J Urogenital Pathol 1: 53–59
Weinstein RS, WA (1992) Urothelial neoplasia. In: Pathology and pathobiology of the urinary bladder and prostate. Williams and Wilkins, Baltimore, pp 77–111
Wolf H, Hojgaard K (1983) Urothelial dysplasia concomittant with bladder tumours as a determinant factor for further new occurrences. Lancet 2: 134
Wood DP, Wartinger DD, Reuter V, Cordon-Cardo C, Faiz WR, Changanti RSK (1991) DNA, RNA and immunohistochemical characterisations of the HER–2/neu oncogene in transitional cell carcinoma of the bladder. J Urol 146: 1398–1401
Wright C, Mellon K, Neal DE, Johnston P, Corbett LP, Home CHW (1990) Expression of C-erb B-2 protein product in bladder cancer. Br J Cancer 62: 764–765
Young RH (1989a) Pathology of the urinary bladder. Churchill Livingstone, New York, pp 78–82
Young RH (1989b) Pathology of the urinary bladder. Churchill Livingstone, New York, p 89
Young RH (1989c) Pathology of the urinary bladder. Churchill Livingstone, New York, pp 139–212
Zing EJ, Wallace DMA (1985) Clinical practice in urology. Bladder cancer. Springer, Berlin Heidelberg New York
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Ooms, E.C.M., Veldhuizen, R.W. (1998). Pathology of Bladder Cancer. In: Petrovich, Z., Baert, L., Brady, L.W. (eds) Carcinoma of the Bladder. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60258-0_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-60258-0_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64323-1
Online ISBN: 978-3-642-60258-0
eBook Packages: Springer Book Archive